The vaccine was approved on the basis of limited, short-term tests that showed the vaccine prevents SOME strains of cervical cancer but not others.
A federal Judge of the Eastern District (Brooklyn) issued a ruling upholding a seal on documents that contain evidence linking Zyprexa, Eli Lilly's antipsychotic drug to diabetes Continue reading →
Merck is lobbying states to MANDATE schoolgirls to be vaccinated with its new vaccine. Continue reading →
"Some politicians, public health officials, mental health activists and pharmaceutical companies have worked to establish mental-health screening programs in schools and the community….Researchers and clinicians, meanwhile, say they are far from having developed accurate predictors of a child developing depression. The younger the child, the murkier the crystal ball." Continue reading →
Tomorrow Hearing FDA’s Emergency Research Rule–CNN News at 8:00 P.M will inform the public about how the FDA Rule impacts on American citizens who can be put at increased risk to test an experimental treatment without their knowledge or consent.
Congress is finally addressing a rip-off by scientists who redeive taxpayer money and don’t show their findings to the public. Continue reading →
The Tacoma Tribune reports that the head of the Center for Disease Control, Dr. Julie Gerberding, has reversed the agency’s bird flu policy, which viewed the threat from the worse-case scenario lens.
The nation’s most powerful legislators have grown accustomed to riding in plush private coporate jets. How does that affect public policy? Continue reading →
We are, however, very distressed at what appears to us to be a significant discrepancy between your statements and the reality of SAMHSA’s role in implementing the NFC report recommendations, as well as other discrepancies between your statements and SAMHSA’s actions.
Continue reading →
This issue is NOT about trial lawyers, this issue is about the rights and health, and safety of ordinary citizens. Continue reading →
Two items in today’s New York Times illustrate the contrast between what the Administration claims it’s legislative / regulatory proposals will do for health care, and what they actually do after they’ve taken effect.
Continue reading →